These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6336892)
21. Relationship of renal histopathology in SLE nephritis to immunoglobulin class of anti-DNA. Clough JD; Valenzuela R Am J Med; 1980 Jan; 68(1):80-5. PubMed ID: 6965338 [TBL] [Abstract][Full Text] [Related]
23. Urinary excretion of antinuclear antibodies. Meryhew NL; Messner RP; Tan EM J Rheumatol; 1983 Dec; 10(6):913-9. PubMed ID: 6363697 [TBL] [Abstract][Full Text] [Related]
24. Mesangial glomerulonephritis and transient SLE manifestations in an adolescent with dermatomyositis. Picco P; Gattorno M; Barbano GC; Trivelli A; Pistoia V; Buoncompagni A Lupus; 1997; 6(1):72-3. PubMed ID: 9116723 [No Abstract] [Full Text] [Related]
25. Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features. Brand CA; Rowley MJ; Tait BD; Muirden KD; Whittingham SF Ann Rheum Dis; 1992 Feb; 51(2):173-6. PubMed ID: 1550399 [TBL] [Abstract][Full Text] [Related]
26. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen. Winn DM; Wolfe JF; Lindberg DA; Fristoe FH; Kingsland L; Sharp GC Arthritis Rheum; 1979 Dec; 22(12):1334-7. PubMed ID: 391237 [TBL] [Abstract][Full Text] [Related]
27. [The direct immunofluorescence skin test in systemic lupus erythematosus. Correlation with the clinical stage of the disease, laboratory changes and nephropathy]. dos Santos RF; Santiago MB; Yoshinari NH; Rodrigues CJ; Cossermelli W Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(4):197-200. PubMed ID: 3074450 [No Abstract] [Full Text] [Related]
28. Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Caneparo V; Cena T; De Andrea M; Dell'oste V; Stratta P; Quaglia M; Tincani A; Andreoli L; Ceffa S; Taraborelli M; Magnani C; Landolfo S; Gariglio M Lupus; 2013 May; 22(6):607-13. PubMed ID: 23612796 [TBL] [Abstract][Full Text] [Related]
30. Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus. Ballou SP; Kushner I Clin Exp Immunol; 1979 Jul; 37(1):58-67. PubMed ID: 385188 [TBL] [Abstract][Full Text] [Related]
31. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function. Sinniah R; Feng PH Clin Nephrol; 1976 Aug; 6(2):340-51. PubMed ID: 782752 [TBL] [Abstract][Full Text] [Related]
32. The utility of the lupus band test on sun-protected non-lesional skin for the diagnosis of systemic lupus erythematosus. Cardinali C; Caproni M; Fabbri P Clin Exp Rheumatol; 1999; 17(4):427-32. PubMed ID: 10464552 [TBL] [Abstract][Full Text] [Related]
33. HLA-DR modulates autoantibody repertoire, but not mortality, in a humanized mouse model of systemic lupus erythematosus. Paisansinsup T; Vallejo AN; Luthra H; David CS J Immunol; 2001 Oct; 167(7):4083-90. PubMed ID: 11564830 [TBL] [Abstract][Full Text] [Related]
34. Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: role of TAP2*01 alleles in Ro autoantibody production. Martín-Villa JM; Martínez-Laso J; Moreno-Pelayo MA; Castro-Panete MJ; Martínez-Quiles N; Alvarez M; de Juan MD; Gómez-Reino JJ; Arnaiz-Villena A Ann Rheum Dis; 1998 Apr; 57(4):214-9. PubMed ID: 9709177 [TBL] [Abstract][Full Text] [Related]
35. The clinical significance of the in vivo antinuclear antibody phenomenon. Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186 [TBL] [Abstract][Full Text] [Related]
36. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex. Bell DA; Rigby R; Stiller CR; Clark WF; Harth M; Ebers G J Rheumatol; 1984 Aug; 11(4):475-9. PubMed ID: 6332909 [TBL] [Abstract][Full Text] [Related]
37. Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features. Gladman DD; Urowitz MB; Keystone EC Am J Med; 1979 Feb; 66(2):210-5. PubMed ID: 218447 [TBL] [Abstract][Full Text] [Related]
38. A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus. Chowdhary VR; Dai C; Tilahun AY; Hanson JA; Smart MK; Grande JP; Rajagopalan G; Fu SM; David CS J Immunol; 2015 Nov; 195(10):4660-7. PubMed ID: 26475924 [TBL] [Abstract][Full Text] [Related]
39. Clinical significance of immune deposits in the skin in SLE. Wertheimer D; Barland P Arthritis Rheum; 1976; 19(6):1249-55. PubMed ID: 793599 [TBL] [Abstract][Full Text] [Related]
40. [New technic for detecting anti-double-stranded DNA antibodies. Value in disseminated lupus erythematosus in children]. Montplaisir S; Courteau C; Pelletier M Arch Fr Pediatr; 1982 Nov; 39(9):685-90. PubMed ID: 6762174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]